Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001735726-21-000003
Filing Date
2021-11-03
Accepted
2021-11-02 17:37:04
Documents
1
Effectiveness Date
2021-11-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10394
  Complete submission text file 0001735726-21-000003.txt   11463
Mailing Address 550 RESERVE STREET SUITE 190 SOUTHLAKE TX 76092
Business Address 550 RESERVE STREET SUITE 190 SOUTHLAKE TX 76092 (682) 712-1581
OncoNano Medicine, Inc. (Filer) CIK: 0001735726 (see all company filings)

EIN.: 811713330 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-378478 | Film No.: 211372725